Gonococcal infection

Gonococcal infection is a bacterial disease caused by *Neisseria gonorrhoeae*, a Gram-negative diplococcus that colonizes mucosal surfaces. The infection is primarily transmitted through sexual contact—vaginal, anal, or oral—or vertically from mother to neonate during childbirth. Infection may localize to the urethra, cervix, rectum, pharynx, or conjunctiva, with variable clinical expression depending on site and host factors. The disease is recognized as a major public health concern due to its high prevalence, frequent asymptomatic presentation, and capacity to cause both local and disseminated complications.

The clinical spectrum ranges from asymptomatic carriage (particularly in women and pharyngeal infections) to acute mucopurulent inflammation of affected sites. In males, common manifestations include urethral discharge and dysuria; in females, symptoms may include vaginal discharge, intermenstrual bleeding, or lower abdominal pain. Complications include pelvic inflammatory disease in women and epididymitis in men. Disseminated infection may result in septic arthritis, dermatitis, or, rarely, endocarditis or meningitis—especially among immunocompromised individuals. Neonates may develop ophthalmia neonatorum if exposed during delivery.

Gonorrhea is globally distributed, with an estimated 0.8% prevalence among women and 0.6% among men. Annual incidence is estimated at 33–106 million new cases worldwide, with approximately 700 deaths reported in 2015. High-risk populations include sexually active individuals under age 25, men who have sex with men (MSM), and pregnant individuals without screening. The disease exhibits seasonal variation in some regions, but no consistent geographic clustering is described in the source material. Surveillance data indicate substantial underreporting due to asymptomatic infection and limited access to diagnostic services.

Transmission occurs primarily through direct mucosal contact during sexual intercourse, including vaginal, anal, and oral routes. Perinatal transmission can occur during childbirth when the infant passes through an infected birth canal. The bacterium does not survive long outside the human body, and casual contact or fomites are not considered significant routes. Pharyngeal and rectal infections may be acquired without penile-vaginal intercourse, highlighting the importance of comprehensive exposure history in risk assessment.

High-risk groups include sexually active individuals under 25 years of age, men who have sex with men (MSM), pregnant individuals without prenatal screening, and those with multiple sexual partners or inconsistent condom use. Infants born to mothers with untreated gonorrhea are at risk for ophthalmia neonatorum. Individuals with compromised immune function face increased risk of disseminated disease, though this is rare in the general population.

Prevention relies on consistent condom use, regular STI screening for high-risk groups—including annual testing for sexually active women <25 years and MSM—and prompt treatment of diagnosed cases to reduce onward transmission. Antimicrobial prophylaxis for neonates (e.g., erythromycin or tetracycline eye ointment) is recommended at birth to prevent ophthalmia neonatorum. No vaccine is currently available. Public health strategies emphasize partner notification and treatment, especially given the high proportion of asymptomatic infections.

Surveillance should prioritize detection of asymptomatic cases, particularly among young sexually active individuals and MSM, as these groups contribute disproportionately to transmission. Laboratory confirmation via nucleic acid amplification tests (NAATs) is preferred over culture where available. Reporting should include site of infection (genital, pharyngeal, rectal), gender, age group, and antimicrobial susceptibility patterns where feasible. Due to the high rate of subclinical infection, surveillance metrics must account for underdiagnosis and incomplete case reporting.

1. 1 Wikidata. pharyngeal gonorrhea.
2. 2 Wikipedia. Gonorrhea - Wikipedia.

ICD-10

ICD-11

Total cases

508K

Peak month

2024-01

Coverage

1 reporting countries · 2000-01-01 → 2026-05-01